PATENT CLAIM ANALYSIS

Application Number: 16161409
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["544", "182000"]

Abstract:
According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A 1 -A 2b  or, particularly, the A 2a  receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy 1  or Het A ; Cy 1  represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy 1  group is optionally substituted by one or more R 4a  substituents; Het A  represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy 2  or Het B ; Cy 2  represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy 2  group is optionally substituted by one or more R 4c  substituents; Het B  represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which Het B  group is optionally substituted by one or more R 4d  substituents.

Claim (Index 40):
The method as claimed in  claim 18 , wherein:\n R 4a  and R 4b  represent, independently at each occurrence, cyclopropyl, iodo, bromo, chloro, fluoro, ethyl, methyl, d 3 -methyl, iso-propyl, \u2014C\u2261CH, phenyl, CF 3 , CHF 2 , CH 2 F, CH 2 CF 3 , CF 2 CF 3 , CN, \u2550O, OH, OCH(CH 3 ) 2 , OCH 3 , OCH 2 CH 3 , OCH 2 F, OCHF 2 , OCH 2 CF 3 , OCF 3 , (CH 2 ) 3 OH, CH 2 OH or CH 2 OCH 3 , CH(CH 3 )OH, C(CH 3 ) 3 OH, CH 2 CH 2 OH, NH 2 , N(CH 3 ) 2 , N(H)CH 2 CH 3 , N(H)C(O)CH 3 , C(O)CH 3 , C(O)N(CH 3 ) 2 , S(O) 2 CH 3 , S(O)CH 3 , SCH 3 , S(O) 2 CF 3 , azetidine, morpholine or dioxolane.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 97.0
- Lexical Diversity: 3.32099
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14322505', '13576798', '15344048', '15488155', '14112484']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8345528362643505
- 35 USC 102 Novelty (BERT): 0.6385717947219824
- Combined Prediction Score: 0.8149547321101137
- Mean Citation Score: 498.28573399999993
- Max Citation Score: 634.10547
- Similarity Product: 556.6190210812872

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test